| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Q32 Bio Inc. | Director | Common Stock | 7.98K | $193K | $24.20 | Mar 25, 2024 | Direct |
| Q32 Bio Inc. | Director | Stock Option (Right to Buy) | 12.8K | $171K | $13.42 | Feb 24, 2025 | Direct |
| Q32 Bio Inc. | Director | Restricted Stock Units | 0 | $0 | $0.57 | Mar 25, 2024 | Direct |
| Stoke Therapeutics, Inc. | Interim Executive Chair, Director | Stock Option (Right to Buy) | 123K | Mar 20, 2025 | Direct | ||
| Stoke Therapeutics, Inc. | Interim Executive Chair, Director | Director Stock Option (Right to Buy) | 7.64K | Jun 5, 2024 | Direct | ||
| Akouos, Inc. | Director | Common Stock | 0 | $12.50 | Nov 30, 2022 | Direct | |
| Akouos, Inc. | Director | Stock Option (right to buy) | 0 | Dec 1, 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| STOK | Stoke Therapeutics, Inc. | Mar 20, 2025 | 1 | $0 | 4 | Mar 20, 2025 | Interim Executive Chair, Director |
| QTTB | Q32 Bio Inc. | Feb 24, 2025 | 4 | $0 | 4 | Feb 27, 2025 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 5, 2024 | 1 | $0 | 4 | Jun 7, 2024 | Director |
| QTTB | Q32 Bio Inc. | Mar 25, 2024 | 3 | -$6.41K | 4 | Aug 14, 2024 | Director |
| QTTB | Homology Medicines, Inc. | Mar 25, 2024 | 1 | $0 | 4 | Mar 27, 2024 | Director |
| STOK | Stoke Therapeutics, Inc. | Feb 13, 2024 | 2 | $69.5K | 4 | Feb 15, 2024 | Director |
| FIXX | Homology Medicines, Inc. | Jan 1, 2024 | 5 | -$7.45K | 4 | Feb 15, 2024 | Director |
| FIXX | Homology Medicines, Inc. | Jun 14, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 13, 2023 | 1 | $0 | 4 | Jun 15, 2023 | Director |
| FIXX | Homology Medicines, Inc. | Jan 9, 2023 | 1 | -$14.8K | 4 | Jan 11, 2023 | Director |
| FIXX | Homology Medicines, Inc. | Jan 1, 2023 | 4 | $0 | 4 | Jan 4, 2023 | Director |
| AKUS | Akouos, Inc. | Nov 30, 2022 | 3 | $0 | 4 | Dec 2, 2022 | Director |
| AKUS | Akouos, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 27, 2022 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 7, 2022 | 1 | $0 | 4 | Jun 8, 2022 | Director |
| FIXX | Homology Medicines, Inc. | Feb 24, 2022 | 2 | $0 | 4 | Feb 28, 2022 | President & CEO, Director |
| FIXX | Homology Medicines, Inc. | Jan 1, 2022 | 3 | -$20.2K | 4 | Jan 12, 2022 | President & CEO, Director |
| AKUS | Akouos, Inc. | Jun 24, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |
| STOK | Stoke Therapeutics, Inc. | Jun 8, 2021 | 1 | $0 | 4 | Jun 25, 2021 | Director |